Thomas Knerr

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fresenius Medical Care Deutschland Gmbh. Active years: 1999-2004.

USPTO Granted Patents = 5

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1

Average Co-Inventor Count = 1.4

ph-index = 5

Forward Citations = 192(Granted Patents)

Company Filing History:

5 out of 882

Fresenius Medical Care Deutschland Gmbh

patents

Years Active: 1999-2004

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6689393 - Solution, in particular for hemodialysis or peritoneal dialysis and a method of preparing same (2004-02-10),

2. 6673376 - Method of preparing a solution, in particular a dialysis or infusion solution (2004-01-06),

3. 6645191 - Multi-chamber container with a concentrated glucose compartment and a concentrated hydrochloric acid compartment (2003-11-11),

4. 6277815 - Solution for peritoneal dialysis (2001-08-21),

5. 5945129 - Process for the production of an infusion or dialysis solution (1999-08-31),

Title: Thomas Knerr: Innovator in Dialysis Solutions

Introduction

Thomas Knerr is a notable inventor based in St. Wendel, Germany. He has made significant contributions to the field of medical solutions, particularly in dialysis. With a total of 5 patents to his name, Knerr's work focuses on improving the efficacy and safety of dialysis treatments.

Latest Patents

One of Knerr's latest patents is a solution specifically designed for hemodialysis or peritoneal dialysis. This innovative solution allows for achieving a desired glucose concentration without altering the concentrations of other essential components. The solution comprises at least three individual solutions that are combined and administered after heat sterilization. The first solution contains calcium ions, electrolyte salts, and optionally glucose, acidified to a pH of less than 4.0. The second solution features glucose at a different concentration than the first, while the third solution includes a buffer within the physiological range. Additionally, Knerr has developed a method for preparing dialysis or infusion solutions, utilizing a storage system that ensures precise mixing ratios through automated dialysis machines.

Career Highlights

Knerr is currently employed at Fresenius Medical Care Deutschland GmbH, a leading company in the field of dialysis products and services. His work has been instrumental in advancing the technology used in dialysis treatments, thereby improving patient outcomes.

Collaborations

Throughout his career, Knerr has collaborated with notable colleagues, including Wendelin Backhaus and Thomas Wild. These partnerships have contributed to the development of innovative solutions in the medical field.

Conclusion

Thomas Knerr's contributions to dialysis solutions exemplify his commitment to enhancing medical treatments. His innovative patents and collaborations reflect his dedication to improving patient care in the field of dialysis.